Company: WELNF
Filing Date: 2025-11-25
Form Type: DEFA14A
Source: 0001104659-25-116055
Chunk: 4

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-11-25
Form: DEFA14A
Chunk 4
---
vii) the effect of the pendency of the Business Combination on Btab’s
business relationships, operating results, and business generally; (viii) risks that the proposed Business Combination disrupts current
plans and operations of Btab; (ix) the outcome of any legal proceedings that may be instituted against Btab or against the Company related
to the Business Combination Agreement or the proposed Business Combination; and (x) those factors discussed in the Company’s filings
with the SEC and in the Proxy Statements. Shareholders should carefully consider the risks and uncertainties described in the “Risk
Factors” section in the annual report on Form 10-K for year ended December 31, 2024 of the Company, filed with the Securities and
Exchange Commission (“SEC”) on April 15, 2025, and the “Risk Factors” sections of the Business Combination
Proxy Statement and the Extension Proxy Statement, and other documents filed from time to time with the SEC. These filings identify and
address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in
the forward-looking statements. There may be additional risks that neither the Company nor Btab presently know or that the Company or
Btab currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements.
In light of these factors, risks and uncertainties, the forward-looking events and circumstances discussed in this Current Report on Form
8-K may not occur, and any estimates, assumptions, expectations, forecasts, views or opinions set forth in this Current Report on Form
8-K should be regarded as preliminary and for illustrative purposes only and accordingly, undue reliance should not be placed upon the
forward-looking statements. The Company and Btab assume no obligation and do not intend to update or revise these forward-looking statements,
whether as a result of new information, future events, or otherwise, except as required by law.

Additional Information

The Company has filed the Extension Proxy Statement
with the SEC in connection with the Extension Meeting on December 12, 2025, and, beginning on or about November 18, 2025, mailed the Extension
Proxy Statement and other relevant documents to its shareholders as of November 3, 2025, the record date for the Extension Meeting. In
connection with the Business Combination, the Company and Btab prepared a registration statement on Form S-4 with the SEC, which includes
a proxy statement that was distributed to the Company’s shareholders in connection with